4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-057489
SVP, COO & CFO sold 8,863 shares at $17.97 ($159,268)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP, COO & CFO | 2019-11-18 | Sale | −8,863 | $17.97 | $159,268 | 219,009 | D: show line 1 in the form |
| Open-market sales · 8,863 sh · avg $17.97 · $159,268 | |||||||
Loading xslF345X03/doc4.xml…